Tuesday, 9 August, 2022
HomeAddiction ResearchSmokers misunderstand risks of smokeless tobacco product snus

Smokers misunderstand risks of smokeless tobacco product snus

SnusAmerican smokers mistakenly think that using snus – a moist snuff smokeless tobacco product popular in Scandinavia but newer to the United States – is as dangerous as smoking tobacco, according to a Rutgers University study published in the April 2019 issue of the journal Addictive Behaviors.

The study provides new research on what smokers think about snus, a Swedish word for snuff, which is a moist powder tobacco that can be sold in a loose form or in small prepacked pouches that users place under the top lip for about 30 minutes. It is typically spit free.

About seven in 100 men use some form of smokeless tobacco in the United States, a figure the Centers for Disease Control and Prevention report is on the rise.

While smokeless tobacco products are addictive, contain cancer-causing chemicals and are linked with cardiovascular and certain cancer risks, products such as snus have comparatively fewer health risks than smoking when used exclusively – not in tandem with smoking – and may serve as harm-reduction alternatives for smokers unable or unwilling to completely quit tobacco.

In Sweden, snus use has been linked to a decrease in tobacco smoking and smoking-related diseases.

The researchers reviewed how 256 smokers responded to questions about their perceived risk of developing lung cancer, heart disease and oral cancer from using snus versus cigarettes, and whether there were subgroups of smokers with similar patterns of beliefs. More than 75 percent of the participants smoked daily and about 20 percent had tried smokeless tobacco.

The researchers found that smokers fell into three subgroups based on their beliefs. About 45 percent perceived snus to be as harmful as smoking overall and for all three risks: lung cancer, heart disease and oral cancer. About 38 percent perceived that snus poses less risk for lung cancer and heart disease than cigarettes but had the same oral cancer risk as cigarettes.

Another 17 percent accurately perceived snus to have lower risks for lung cancer but perceived risks for oral cancer and heart disease to be about the same as that from smoking. Almost 40 percent incorrectly perceived the risk of oral cancer to be higher from snus use than smoking.

"These findings continue to suggest that the public does not understand that combustion escalates the health risks in tobacco products that are smoked, making them more harmful than non-combusted smokeless tobacco on a continuum of risk," said lead researcher Olivia Wackowski, assistant professor of Health Behavior, Society and Policy at Rutgers School of Public Health and a member of the Rutgers Center for Tobacco Studies and Rutgers Cancer Institute of New Jersey.

"They are also significant given that use of Scandinavian snus has not been clearly associated with oral cancer, unlike smoking, which poses a significant risk for oral cancer."

Quitting all tobacco is the best course of action. However, smokers who have not been successful in quitting or who do not want to quit tobacco entirely may be able to reduce their risks by learning about and switching to a product like snus, Wackowski said.

But this information can be challenging to communicate and is a key area for research work. It's important for smokers to know that the reduced risks may come from completely switching over from smoking to snus use, and not using both products, she said.

It's also important that such messaging does not unintentionally encourage product initiation among non-users, especially youth.

The study was co-authored by Anne Ray, an instructor of Health Behavior, Society and Policy at the Rutgers School of Public Health, and Jerod Stapleton, associate professor of medicine at Rutgers Robert Wood Johnson Medical School and faculty member at Rutgers Cancer Institute of New Jersey.


Smokers' perceptions of risks and harm from snus relative to cigarettes: A latent profile analysis study

Addictive Behaviors, Volume 91, April 2019


Olivia A Wackowski, Anne E Ray and Jerod L Stapleton.


Certain types of smokeless tobacco (SLT) products, particularly snus, carry fewer health risks than cigarette smoking and might be able to serve as harm-reduction products for smokers. However, studies frequently find that smokers misperceive SLT and snus to be as or more harmful than smoking. This perception is often measured with a single general harm question, and research on underlying risk perceptions is limited.


Using a sample of 256 current smokers, we utilised Latent Profile Analysis to examine response profiles to items that assessed perceived risk of specific health outcomes (lung cancer, heart disease, oral cancer) from snus relative to cigarettes, along with the typical single item measure of overall harm from snus compared to cigarettes.


Three smoker response profiles emerged. Almost half (44.9%) of smokers perceived snus to be as or more risky than cigarettes for all three specific health outcomes (group 1), while over one third (38.3%) had an elevated perceived risk for oral cancer only (group 2). About 17% of smokers perceived snus to have lower risks for lung canceronly (group 3). Across each profile, perceived risk was highest for oral cancer.


If smokers are to consider snus for harm-reduction, efforts may be needed to better inform smokers about their lower relative risks, including for particular health outcomes of interest. This study also suggests that smokers may vary in their level of need for information to correct their relative risk misperceptions.

[link url="https://news.rutgers.edu/research-news/smokers-often-misunderstand-health-risks-smokeless-tobacco-product-rutgers-study-finds/20190228#.XIDtZC2B3Eb"]Smokers often misunderstand health risks of smokeless tobacco product, Rutgers study finds[/link]

[link url="https://www.sciencedirect.com/science/article/abs/pii/S0306460318313091"]Smokers' perceptions of risks and harm from snus relative to cigarettes: A latent profile analysis study[/link]



MedicalBrief — our free weekly e-newsletter

We'd appeciate as much information as possible, however only an email address is required.